Studies have demonstrated that EBN supplementation improves glucose metabolism and insulin sensitivity in obesity-induced insulin-resistant rats and mice [42,43,47], menopause-induced insulin-resistant rats [48], type 1 diabetic rats [69,70,71], and type 2 diabetic mice [72]. Here, INS is linked to obesity disorder.